BASINGSTOKE, England and CAMBRIDGE, Massachusetts, August 13 /PRNewswire-FirstCall/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that since July 3, 2008 it has acquired 81% of the shares in Jerini AG through its wholly owned indirect subsidiary Shire Deutschland Investments GmbH (formerly Maia Elfte Vermogensverwaltungs-GmbH), which today also published an Offer Document in respect of the remaining outstanding shares in Jerini.
The intention to make the voluntary takeover offer for a cash consideration of EUR6.25 per share was announced on July 3, 2008.
The offer period will expire on 10 September 2008, 24.00 CEST and the offer can be accepted until the last day of any additional acceptance period.
A copy of the Offer Document is published on Shire's website at http://www.shire.com. Details of market purchases after the publication of the Offer Document will also appear on Shire's website.
This press release is neither an offer to purchase nor a solicitation of an offer to sell shares in Jerini AG, nor an offer to purchase or sell any other securities. The terms and conditions of the Offer are being published in the offer document as approved by BaFin. Investors and holders of shares in Jerini AG are strongly advised to read the relevant documents regarding the takeover offer published by Shire Deutschland Investments GmbH, in particular the offer document, because they contain important information. Investors and holders of shares in Jerini AG may review these documents at the web site http://www.shire.com.
Notice to US holders of Jerini shares
In accordance with normal German market practice, and pursuant to
exemptive relief granted by the SEC, the Bidder or its nominees or brokers
(acting as agents) may from time to time make ce
|SOURCE Shire Ltd|
Copyright©2008 PR Newswire.
All rights reserved